Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Saved in:
Bibliographic Details
Title: Li-Fraumeni syndrome: cancer risk assessment and clinical management.
Authors: McBride KA; The Familial Cancer Service, Crown Princess Mary Cancer Centre, Sydney Medical School, Westmead Millennium Institute, Westmead, NSW 2145, Australia., Ballinger ML; Research Division, Sir Peter MacCallum Department of Oncology, University of Melbourne, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia., Killick E; Medical Oncology Unit, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK., Kirk J; The Familial Cancer Service, Crown Princess Mary Cancer Centre, Sydney Medical School, Westmead Millennium Institute, Westmead, NSW 2145, Australia., Tattersall MH; Department of Cancer Medicine, Sydney Medical School, Royal Prince Alfred Hospital, Camperdown, NSW 2040, Australia., Eeles RA; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK., Thomas DM; The Kinghorn Cancer Centre and Garvan Institute, Darlinghurst, NSW 2010, Australia., Mitchell G; The Familial Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2014 May; Vol. 11 (5), pp. 260-71. Date of Electronic Publication: 2014 Mar 18.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-4782
DOI:10.1038/nrclinonc.2014.41